An enhanced oxygenation device, that purportedly promotes pancreatic beta cell differentiation in vitro, has been designed by scientists at the Diabetes Research Institute at the University of Miami. According to Amy from Diabetes Mine, who alerted us to this story, the device has the potential to make a significant improvement for the whole business of beta cell transplantation. The device uses perfluorocarbons, well-known oxygen carrier molecules, to improve oxygenation of the extracellular environment.
From the original press release:
Up until now investigators have had only moderate success in differentiating either adult stem cells or embryonic stem cells to become insulin-producing beta cells.
A large part of the problem has been inducing the proper culture environment in the laboratory. Researchers know that islets require a high amount of oxygen for optimal health, so DRI researchers created a new cell culture device called the “oxygen sandwich” to provide the cells with a more natural oxygen environment than those used in traditional culture methods.
“Using mouse pancreatic stem cells, we were able to show that delivering oxygen in a physiological way enhanced enormously their differentiation into beta cells, with insulin levels exceeding 30-fold those observed in control conditions,” said Juan Domínguez-Bendala, Ph.D., research assistant professor of surgery, director of the Stem Cell Development and Translational Research Laboratory at the Diabetes Research Institute, and senior author of the study which was published online in Stem Cells Express.
“It is as though these stem cells were just waiting for us to provide them with the conditions they needed to mature. We believe this is a major step toward the efficient generation of beta cells for clinical transplantation.”
The new cell culture device, designed by Chris Fraker, senior research associate in the Tissue Engineering Laboratory at the Diabetes Research Institute, closely mimics the natural oxygen environment. The device “sandwiches” the stem cells with oxygen from two sources, one from the top with air diffusing through the culture medium and the second from the bottom with air diffusing through a silicon membrane mixed with perfluorocarbon, a very powerful oxygen reservoir.
“The use of high oxygen to promote differentiation of insulin-producing cells opens the way to many other applications with different sources of progenitor cells, beyond embryonic stem cells and beyond diabetes,” said Camillo Ricordi, M.D., scientific director of the Diabetes Research Institute.
Press release: DRI INVENTION PROMOTES INCREASE IN INSULIN PRODUCING CELLS…
Paper: Enhanced oxygenation promotes beta cell differentiation in vitro (.pdf) (Stem Cells Express, published online August 30, 2007; doi:10.1634/stemcells.2007-0445)